When Making Babies Goes High Tech: A Future Tense Event Recap
By Ariel Bogle,
Slate
| 11. 24. 2014
[Quotes CGS's Marcy Darnovsky]
Untitled Document
In vitro fertilization was originally intended to help a very specific young, married, and female demographic to conceive. But a lot has changed since Louise Brown, the first test tube baby, was born in 1978. The explosion of single mothers and same-sex parents using the procedure has attracted a lot of attention, but society also needs to grapple with the questions of control, regulation, and access that other emerging reproductive technologies could raise. From pre-implantation genetic screening to exo-wombs, these changes could even evolve our most basic notions of family and society.
A first step may be agreeing to talk about this possible future at all. The highly personal nature of reproductive science and technology makes it a difficult topic to discuss and legislate, according to speakers at a Future Tense event on the future of reproduction in Washington, D.C., last week. After all, we’re not talking about hip replacement surgery; this is our future children and grandchildren. As Dieter Egli, a senior research fellow at the New York Stem Cell Foundation, put it: “When we touch the...
Related Articles
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Jay S. Kaufman, Los Angeles Review of Books | 09.27.2025
This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...